Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹812 Cr₹1,377 Cr₹905 Cr₹868 Cr₹883 Cr

What is the latest Total Non-Current Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of EMCURE PHARMACEUTICALS is ₹812 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹812 Cr
Mar2024₹1,377 Cr
Mar2023₹905 Cr
Mar2022₹868 Cr
Mar2021₹883 Cr

How is Total Non-Current Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹812 Cr
-41.04
Mar2024 ₹1,377 Cr
52.24
Mar2023 ₹905 Cr
4.16
Mar2022 ₹868 Cr
-1.64
Mar2021 ₹883 Cr -

Compare Total Non-Current Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹30,259.2 Cr 8.5% 11.5% 55.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

8.5%

11.5%

55.7%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses